St. Jude Medical founder Manny Villafaña’s Medical 21 filed an amendment to an SEC Form D to reveal that it raised more than $1.1 million in an equity offering. The Minneapolis-based company raised a total of $1.14 million in a $10 million offering, leaving $8.86 million remaining to be sold, according to the SEC filing. […]
Gore announces some Excluder problems in Europe
W.L. Gore & Associates issued an urgent field safety notice in Europe to warn on issues with its Excluder AAA Endoprosthesis and Excluder Iliac Branch. Both Excluder products may experience the separation of the leading end of catheter components, according to the safety notice out of Germany. From January 2013 to Aug. 5, 2019, Gore […]
AngioDynamics starts postmarket study
AngioDynamics (NSDQ:ANGO) announced today that it launched a postmarket study of its Auryon atherectomy system for treating lesions in patients with peripheral artery disease (PAD). The Auryon atherectomy system, previously known as the Eximo B-Laser, is a wavelength laser technology platform that AngioDynamics acquired in October 2019. The system is designed to treat de novo, re-stenotic […]
Reva Medical files for bankruptcy
Reva Medical (ASX:RVA) announced today that it has filed for Chapter 11 bankruptcy protection. San Diego-based Reva — which specializes in bioresorbable polymer tech for vascular applications — entered into a restructuring support agreement with a handful of its stakeholders last month. The goal was to address the company’s outstanding debt. Reva also filed a prepackaged […]
Miles White’s fearless strategy for growing Abbott
With strong leadership and a taste for risk-taking, outgoing CEO Miles White left no stone unturned as he grew Abbott into one of the world’s largest medical device companies. Few medical device companies have seen the growth and transformation that Abbott (NYSE:ABT) has seen under the leadership of Miles White. During his two decades as […]
Teleflex warns on Arrow EZ-IO needle sets
Teleflex (NYSE:TFX) today issued a safety warning in the United Kingdom for its Arrow EZ-IO intraosseous vascular access needle sets due to a risk of needle stick injury. The company informed users that they should not use the affected needles if the safety cap is not in place, due to a risk of needle stick […]
Velano Vascular adds $25m for $50m total
Velano Vascular announced today that it closed the second tranche of a $25 million growth financing to bring its total funding to more than $50 million. The total funding collected from insiders, venture capital firms, hospital partners and undisclosed healthcare industry multinationals is earmarked for Velano’s planned commercialization and the launch of additional inpatient medical […]
Venclose closes $27m Series C
Venous reflux disease treatment developer Venclose announced that it closed a Series C funding round totaling $27 million. Venclose develops the next-generation Venclose RF ablation system designed to close damaged veins and restore healthy blood flow in patients with venous reflux disease. The San Jose, Calif.–based company said that, after securing the $27 million, it […]
Penumbra appoints new chief financial and accounting officers
Penumbra (NYSE:PEN) recently announced that it appointed Maggie Yuen as chief financial officer and Lambert Shiu as chief accounting officer, effective Dec. 2. Yuen replaces president and chief financial officer Sri Kosaraju. Kosaraju will continue to serve as president following the appointment. Prior to joining Penumbra, Yuen held a number of leadership roles in the manufacturing, […]
Merit Medical lands breakthrough designation for dialysis stent graft system
Merit Medical (NSDQ:MMSI) announced last week that it has been granted FDA breakthrough device designation for its Wrapsody endovascular stent graft system. Wrapsody is a flexible, self-expanding endoprosthesis designed for hemodialysis patients. Merit said it will seek indication to treat stenosis within the central veins of the outflow circuit of an arteriovenous fistula (AVF) up […]
Stent makers point to quality-of-life findings by massive federal study
The giant federal study that found the use of stents in stable heart-disease patients is no better than drugs to treat clogged arteries reached another, less-hyped conclusion. Manufacturers of stents for percutaneous coronary intervention (PCI) note that the Ischemia study also concluded that patients who undergo a stenting procedure have a better quality of life. They suffer […]
- 1
- 2
- 3
- …
- 75
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube